Zist Arvand Pharma

Zist Arvand Pharma is a prominent Iranian pharmaceutical company specializing in the development and production of high-tech medicinal products, with a particular focus on complex generics and biosimilars. The company is a leader in the neurology market, providing a comprehensive range of oral disease-modifying therapies for Multiple Sclerosis, including teriflunomide and fingolimod. Beyond neurology, Zist Arvand Pharma has expanded its portfolio into oncology and hematology, producing advanced small molecules and monoclonal antibodies. The company operates state-of-the-art manufacturing facilities in the Simindasht Industrial Park that comply with international Good Manufacturing Practice (GMP) standards. By leveraging strong internal R&D capabilities, Zist Arvand Pharma aims to provide affordable access to life-saving medications for patients in Iran and the broader MENA region.